Alnylam Pharmaceuticals
Kirk Brown is an experienced professional who has worked in various research and development roles in the pharmaceutical and life sciences industry. Kirk currently holds the position of Vice President of Research at Alnylam Pharmaceuticals and has previously worked at companies such as Biogen, NABsys, Caris Life Sciences, and Thermo Fisher Scientific. Kirk has a strong educational background with a Ph.D in Microbiology and Molecular Genetics and has conducted research in areas such as biomarker development, microRNA detection, and RNAi technology. Throughout their career, Kirk has demonstrated expertise in nucleic acid biomarker discovery and has contributed to advancements in the field of biochemistry and molecular pharmacology.
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.